MARKET CLOSE: NZ shares rise as vaccine trial boosts global sentiment

MARKET CLOSE: NZ shares rise as vaccine trial boosts global sentiment
Dan Brunskill
New Zealand shares rose for a third day as investors welcomed interim results of a covid-19 vaccine trial which showed a positive immune response to the virus. The S&P/NZX 50 Index rose 116.38 points, or 1 percent, to 11,610.52. Within the index, 34 stocks rose and 16 fell. Turnover was $186.9 million. The experimental vaccine, developed by biotech company Moderna, safely induced an immune response against covid-19 in all 45 participants, researchers reported in The New England Journal of Medicine. Moderna has now announced that a phase 3...

More Markets

International winds of uncertainty blow over NZ sharemarket
Markets Market Close

International winds of uncertainty blow over NZ sharemarket

Markets enter a quiet period after the reporting season. 

Infratil's renewables stake drops by US$133m
Markets

Infratil's renewables stake drops by US$133m

Infratil provided updated valuations on three investments.

John Anthony 07 Mar 2025
NZME board spill support builds towards 50%
Markets

NZME board spill support builds towards 50%

An update to the NZX says more shareholders are expressing support for board changes.

Pattrick Smellie 07 Mar 2025
Tech titans eye NZ's new golden visas
Policy

Tech titans eye NZ's new golden visas

Investors with tens of millions were 'priced out of the market'. Not any more.